Hereditary Hemorrhagic Telangiectasia (HHT) Center

$2.29M USD

Funder	Health Resources and Services Administration
Recipient Organization	Not specified
Country	USA
Start Date	Mar 16, 2026
End Date	Oct 01, 2029
Duration	1,295 days
Number of Grantees	1
Data Source	Grants.gov
Grant ID	`6473c37b-b615-4775-aa71-1964ae58140b`

Grant Description

The purpose of the Hereditary Hemorrhagic Telangiectasia (HHT) Center Program is to reduce illness and death related to HHT by partnering with clinical center to expand access and coordination of care; creating innovative strategies that support clinicians with identifying and diagnosing HHT cases; and developing a de-identified, aggregate patient data registry to better understand this rare disease and its treatment outcomes.